These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15029097)

  • 1. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
    Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
    Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
    Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
    Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
    Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
    J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
    Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
    Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
    O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
    D'Antonio JA; Ellis D; Doft BH; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1989; 12(10):694-70. PubMed ID: 2612304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study.
    Rathsman B; Haas J; Persson M; Ludvigsson J; Svensson AM; Lind M; Andersson Franko M; Nyström T
    J Intern Med; 2021 Jun; 289(6):873-886. PubMed ID: 33283333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
    Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
    Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial dysfunction, neuropathy and nephropathy in long standing type 1 diabetic patients].
    Galicka-Latała D; Konduracka E; Kuźniewski M; Fedak D; Sieradzki J
    Przegl Lek; 2005; 62(12):1451-4. PubMed ID: 16786771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study.
    Wan EYF; Yu EYT; Chin WY; Lau CST; Mok AHY; Wang Y; Wong ICK; Chan EWY; Lam CLK
    Sci Rep; 2021 Apr; 11(1):8047. PubMed ID: 33850209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.